Analysts’ Viewpoint on Market Scenario
Growth in investment in R&D of fast-dissolving oral films and rise in demand for thin-film drug delivery systems are driving the oral thin films market size.
Demand for Oral Thin Films (OTFs) is high due to their ability to incorporate even poorly soluble drugs. Rise in adoption of patient-friendly drug delivery systems is expected to augment market expansion during the forecast period.
OTFs can be wetted, dissolved, and disintegrated much more quickly than other drug delivery methods due to their significantly larger surface area. They can also be made to have a pleasing color and flavor in order to appeal to young children.
Market vendors are investing significantly in pre-development, formulation, and clinical supply manufacturing of new products to increase their oral thin films market share.
The pharmaceutical industry is seeking new ways to deliver drugs using thin films. OTFs are very thin films made of a mono or multi-layer polymeric matrix. They are often water-based, soluble polymers that are intended for rapid drug delivery. Thin films are an alternative to conventional dosage forms. They are flexible systems that offer immediate, regional, or systemic effects.
The oral thin-film technology is simple to use and beneficial for patients who have difficulty swallowing and/or are young, elderly, or bedridden. These drug delivery systems can be administered orally, buccally, sublingually, ocularly, and transdermally.
OTFs can be termed ‘precision medication,’ as they have perforations in a single film that provide accurate and flexible dosing. They are ideal for children who need smaller and more variable doses. Adults who want to take partial doses of medication can also rely on oral thin films.
Various studies are investigating capable new particle engineering techniques to discover innovative ways to increase the solubility of water-insoluble drugs in OTFs.
However, OTFs can only transport a relatively small drug load of 10 to 20 mgs. Future research can help establish OTFs as a common dosage form for all pharmaceuticals.
Request a sample to get extensive insights into the Oral Thin Films Market
Fast-dissolving oral film is the latest advanced oral solid dosage form. It offers greater flexibility and comfort. Fast-dissolving oral films improve API effectiveness by dissolving in the oral cavity within minutes after contact with saliva without chewing.
Fast-dissolving oral films do not require water for administration. These drugs are absorbed quickly and have instant bioavailability due to the high blood flow and absorption of the oral mucosa. These benefits are likely to propel the oral thin films business growth in the next few years.
Oral route is the most efficient option for drug delivery. However, it is often inconvenient for elderly and pediatric patients. Orally disintegrating films have demonstrated effectiveness in distributing quick drug action by dissolving the drug in the buccal cavity.
Over the last decade, oral thin films have grown in marketable importance in both generic and non-generic markets. Researchers are constantly seeking new strategies to create advanced, modern dosage designs that are not only safe and effective but also savvy and simple to deliver.
The final form of OTFs allows for quick production with the development of aqueous-based film manufacturing that does not require solvents. This process is efficient, as it requires just two steps of combining, followed by casting, while producing tablets and capsules is far more complicated.
Drugs delivered via OTFs are helpful for people who have difficulty swallowing, such as young children, the elderly, and people who experience nausea. Thus, more medications for a wider range of disease indications are likely to be converted to oral thin films in the near future. Rise in geriatric population is also projected to augment oral thin films market progress in the next few years.
Oral fast-dissolving film is a cutting-edge, patient-friendly, and inventive delivery method. This innovative dosage form is gaining traction due to several benefits, including rapid dissolution without the use of water and high compliance with both geriatric and pediatric patients in urgent situations and specific diseases. It is also a beneficial dosage form for a drug, which has lower bioavailability and pre-systemic metabolism.
OTFs have a much larger surface area than other drug delivery methods. This allows for faster disintegration, wetting, and dissolution. OTFs can have a pleasing flavor and color, making them suitable for young children.
Request a custom report on Oral Thin Films Market
According to the latest oral thin films market in-depth analysis, the sublingual film product segment held significant share in 2021. Thin membrane structure and high level of vascularization of sublingual mucosa result in a high membrane permeability. Sublingual mucosa offers very good bioavailability.
Better permeability can be ascribed to increased blood flow and lymphatic circulation, which skips the first-pass effect and results in increased systemic bioavailability.
Drugs are administered sublingually by placing them under the tongue. The sublingual route avoids first-pass metabolism, which accelerates the drug's entry into the systemic circulation.
The drug directly enters the systemic circulation using blood vessels. Significant research activities, a strong product pipeline, and high adoption of sublingual films are driving the segment.
The neurosurgical disorder indication segment is expected to dominate the oral thin films market during the forecast period. Growth of the segment can be ascribed to high prevalence of neurological disorders across the globe. Neurological disorders are the third leading cause of disability and premature death in the European Union.
Oral thin films are ideal for therapies requiring rapid drug absorption, such as pain, allergies, sleep disorders, and disorders of the nervous system.
The retail pharmacies distribution channel segment is projected to account for major share of the global oral thin films market during the forecast period. High preference for retail pharmacies, easy availability of a wide range of products and home delivery, and increase in number of retail pharmacies in developing countries are boosting the segment.
The online pharmacies segment is likely to be driven by expansion in the e-commerce sector and rise in convenience in choosing a wide range of oral thin film products.
North America is anticipated to dominate the business during the forecast period. Increase in investment in R&D activities and rise in approval and launch of new oral thin films are fueling the market share of the region.
The industry in Asia Pacific is expected to grow at a significant pace during 2022 to 2031. High presence of local and global oral thin film manufacturers, increase in geriatric population, and surge in healthcare expenditure are propelling market development in the region.
The market is home to a small number of dominant players. The oral thin films market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments. Most of the firms are adopting M&A, product development and launch, collaboration, and partnership strategies to increase their revenue share.
Aquestive Therapeutics, Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy's Laboratories, Indivior plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co., Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co., Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals, Inc., and ZIM Laboratories Limited are key entities operating in this industry.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 2.9 Bn |
|
Market Forecast Value in 2031 |
More than US$ 7.1 Bn |
|
Growth Rate (CAGR) |
9.3% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis and regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 2.9 Bn in 2021.
It is projected to reach more than US$ 7.1 Bn by 2031.
It is anticipated to be 9.3% from 2022 to 2031.
Investment in R&D of fast-dissolving oral films and rise in demand for thin-film drug delivery systems.
North America is expected to account for major share from 2022 to 2031.
Aquestive Therapeutics, Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy's Laboratories, Indivior plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co., Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co., Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals, Inc., and ZIM Laboratories Limited.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oral Thin Films Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Oral Thin Films Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
5.5. Insights on Development of Advanced Drug Delivery Systems
6. Global Oral Thin Films Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Sublingual Film
6.3.2. Fast-dissolving Oral Film
6.3.3. Buccal Film
6.4. Market Attractiveness Analysis, by Product
7. Global Oral Thin Films Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Pain Management
7.3.2. Neurological Disorders
7.3.3. Nausea & Vomiting
7.3.4. Opioid Dependence
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Oral Thin Films Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Oral Thin Films Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Oral Thin Films Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Sublingual Film
10.2.2. Fast-dissolving Oral Film
10.2.3. Buccal Film
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Pain Management
10.3.2. Neurological Disorders
10.3.3. Nausea & Vomiting
10.3.4. Opioid Dependence
10.3.5. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Indication
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Oral Thin Films Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Sublingual Film
11.2.2. Fast-dissolving Oral Film
11.2.3. Buccal Film
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Pain Management
11.3.2. Neurological Disorders
11.3.3. Nausea & Vomiting
11.3.4. Opioid Dependence
11.3.5. Others
11.4. Market Value Forecast, by Distribution Channel, 2017–2031
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Indication
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Oral Thin Films Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Sublingual Film
12.2.2. Fast-dissolving Oral Film
12.2.3. Buccal Film
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Pain Management
12.3.2. Neurological Disorders
12.3.3. Nausea & Vomiting
12.3.4. Opioid Dependence
12.3.5. Others
12.4. Market Value Forecast, by Distribution Channel, 2017–2031
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Indication
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Oral Thin Films Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Sublingual Film
13.2.2. Fast-dissolving Oral Film
13.2.3. Buccal Film
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Pain Management
13.3.2. Neurological Disorders
13.3.3. Nausea & Vomiting
13.3.4. Opioid Dependence
13.3.5. Others
13.4. Market Value Forecast, by Distribution Channel, 2017–2031
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Indication
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Oral Thin Films Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Sublingual Film
14.2.2. Fast-dissolving Oral Film
14.2.3. Buccal Film
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Pain Management
14.3.2. Neurological Disorders
14.3.3. Nausea & Vomiting
14.3.4. Opioid Dependence
14.3.5. Others
14.4. Market Value Forecast, by Distribution Channel, 2017–2031
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Indication
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Aquestive Therapeutics, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. C.L. Pharm
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cure Pharmaceutical
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Dr. Reddy's Laboratories
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Indivior plc
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. IntelGenx Corp.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Kyu Kyu Pharmaceutical Co., Ltd.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. DK Livkon Pvt. Ltd.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. NAL Pharma
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Seoul Pharma Co., Ltd.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Shilpa Therapeutics Pvt. Ltd.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. ZIM Laboratories Limited
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Sunovion Pharmaceuticals Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Other Prominent Players
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
List of Tables
Table 01: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 03: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 04: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 08: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 09: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 12: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 16: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 17: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 20: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 21: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 24: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Oral Thin Films Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031
Figure 02: Global Oral Thin Films Market Revenue (US$ Mn), by Product, 2021
Figure 03: Global Oral Thin Films Market Value Share, by Product, 2021
Figure 04: Global Oral Thin Films Market Revenue (US$ Mn), by Indication, 2021
Figure 05: Global Oral Thin Films Market Value Share, by Indication, 2021
Figure 06: Global Oral Thin Films Market Revenue (US$ Mn), by Distribution Channel, 2021
Figure 07: Global Oral Thin Films Market Value Share, by Distribution Channel, 2021
Figure 08: Global Oral Thin Films Market Value Share, by Region, 2021
Figure 09: Global Oral Thin Films Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Global Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031
Figure 11: Global Oral Thin Films Market Attractiveness Analysis, by Product, 2022-2031
Figure 12: Global Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031
Figure 13: Global Oral Thin Films Market Attractiveness Analysis, by Indication, 2022-2031
Figure 14: Global Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 15: Global Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 16: Global Oral Thin Films Market Value Share Analysis, by Region, 2017 and 2031
Figure 17: Global Oral Thin Films Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Oral Thin Films Market Attractiveness Analysis, by Country, 2017–2031
Figure 20: North America Oral Thin Films Market Value Share Analysis, by Country, 2017 and 2031
Figure 21: North America Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031
Figure 22: North America Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031
Figure 23: North America Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 24: North America Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031
Figure 25: North America Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031
Figure 26: North America Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 27: Europe Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 29: Europe Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 30: Europe Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031
Figure 31: Europe Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031
Figure 32: Europe Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 33: Europe Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031
Figure 34: Europe Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031
Figure 35: Europe Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 36: Asia Pacific Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 38: Asia Pacific Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 39: Asia Pacific Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031
Figure 40: Asia Pacific Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031
Figure 41: Asia Pacific Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 42: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031
Figure 43: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031
Figure 44: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 45: Latin America Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 47: Latin America Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 48: Latin America Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031
Figure 49: Latin America Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031
Figure 50: Latin America Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 51: Latin America Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031
Figure 52: Latin America Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031
Figure 53: Latin America Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Figure 54: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 56: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
Figure 57: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031
Figure 58: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031
Figure 59: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031
Figure 60: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031
Figure 61: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031
Figure 62: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Oral Thin Films Market
